Field Intelligence for Pharma

What happens in the field
should reach leadership.

Memorera turns every rep visit into structured intelligence — competitor trends, objections, doctor requests — ready to act on.

Contact Us
<15%
of field insights reach leadership today
6
signal types extracted per visit
100%
visit coverage, no manual effort
89%
average signal confidence score
The Platform

Every metric linked to
the visit behind it.

Click any row and the exact field snippet opens. Every number is defensible. Every insight is audit-ready. This isn't a reporting tool — it's a decision engine.

Contact Us
Field Intelligence · Feb 2026 · All Territories
Visits Processed
248
100% coverage
Signals Extracted
187
↑ 32% vs last
Avg Confidence
89%
audit-ready
Competitor
Mentions
% Visits
Δ Period
BrandX
47
19%
↑ 41%
BrandY
42
17%
↑ 18%
BrandZ
31
13%
↓ 6%
"Mentioned BrandX discussed at tumor board following recent ASCO efficacy data."
Dr. Torres · Oncology · SW · Feb 4 · conf 87% · mem_1839 · v1.2
Weekly Intelligence BriefFeb 3–7, 2026
Alert
BrandX up 41% in Northeast Oncology — linked to 14 safety objections.
→ Prepare safety data packet before Monday.
Opportunity
Clinical data requests up 21% — Oncology asking for ASCO trial data.
→ Prioritize trial reprints this week.
Win
Dosing objections down 27% since new card launch Jan 15.
→ Expand to all territories.
Action
22 visits requesting Spanish patient materials — Southeast blocking.
→ Fast-track translation.
Weekly Brief

248 visits.
Four decisions.
Monday morning.

Auto-generated every week. Competitive threats, wins, and actions — with the evidence behind each one. No manual reporting.

What We Track

Six signal types.
Every visit.

⚔️
Competitor Mentions
Who came up, in what context, and how often — with territory and linked objections.
brandcontext% visitsΔ period
🚫
Objection Types
Dosing, safety, cost, prior auth, formulary — ranked, linked to competitors, broken down by specialty.
6 categoriescompetitor linkterritory
📋
Doctor Requests
Clinical data, samples, patient materials, pricing — what doctors ask for is a buying signal.
request type% visitstrending
⚠️
Adverse Events
AE mentions surfaced from field notes — auto-flagged with patient group and compliance status.
AE typepatient groupPHI flag
📈
Engagement Signals
Doctor sentiment, follow-up rates, visit outcomes — tracked over time by territory and segment.
sentimentfollow-up %trend
🔒
Access Barriers
Prior auth, formulary issues, reimbursement — caught before they become quota misses.
barrier typeterritoryinsurance
Trust & Compliance

Built for pharma.
Not bolted on.

🔐 PHI Auto-Detection
Patient identifiers removed before any signal enters the intelligence layer.
⚠️ Off-Label Quarantine
Auto-flagged and held in draft. Blocked from publishing until reviewed by legal.
📊 Confidence Scores
Every signal scored. Filter by threshold. Every metric is defensible in a boardroom.
🔗 Full Traceability
memory_id · chunk_id · rep · date · territory · extractor version. Every number is auditable.
✅ Draft → Review → Publish
Three-stage approval. Nothing sensitive surfaces without a human sign-off.
🏢 Org-Level Isolation
Row-level security. SSO-ready. Data never crosses organizational boundaries.

Your team is already generating
the intelligence.
Stop losing it.

30-minute demo. We'll show you what your field data looks like — processed and actionable.

Contact Us